BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22434616)

  • 1. Impact of cardiac rehabilitation on metabolic syndrome in Iranian patients with coronary heart disease: the role of obesity.
    Kabir A; Sarrafzadegan N; Amini A; Aryan RS; Kerahroodi FH; Rabiei K; Taghipour HR; Moghimi M
    Rehabil Nurs; 2012; 37(2):66-73. PubMed ID: 22434616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
    Zabetian A; Hadaegh F; Azizi F
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs.
    Savage PD; Banzer JA; Balady GJ; Ades PA
    Am Heart J; 2005 Apr; 149(4):627-31. PubMed ID: 15990744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients.
    Lavie CJ; Morshedi-Meibodi A; Milani RV
    J Cardiometab Syndr; 2008; 3(3):136-40. PubMed ID: 18983328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and C-reactive protein among cardiology patients.
    Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
    Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects.
    Esteghamati A; Noshad S; Khalilzadeh O; Morteza A; Nazeri A; Meysamie A; Esteghamati A; Nakhjavani M
    Arch Med Res; 2011 Apr; 42(3):244-51. PubMed ID: 21722822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of individual components, time, and sex on prevalence of metabolic syndrome in adolescents.
    Daratha KB; Bindler RC
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):365-70. PubMed ID: 19349566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diastolic functions and myocardial performance index in obese patients with or without metabolic syndrome: a tissue Doppler study.
    Koç F; Tokaç M; Kaya C; Kayrak M; Yazıcı M; Karabağ T; Vatankulu MA; Ayhan S; Demir K
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):400-4. PubMed ID: 21200118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term cardiac rehabilitation and exercise training programs improve metabolic parameters in metabolic syndrome patients with and without coronary heart disease.
    Gayda M; Brun C; Juneau M; Levesque S; Nigam A
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):142-51. PubMed ID: 17142023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
    Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
    Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
    Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in obesity and coronary risk factors after high caloric exercise training in overweight coronary patients.
    Savage PD; Brochu M; Poehlman ET; Ades PA
    Am Heart J; 2003 Aug; 146(2):317-23. PubMed ID: 12891202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-country study on the components of the metabolic syndrome in youths: the BIG Study.
    Schwandt P; Kelishadi R; Ribeiro RQ; Haas GM; Poursafa P
    Int J Pediatr Obes; 2010 Aug; 5(4):334-41. PubMed ID: 20233158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.